Chemoinformaics analysis of (11E,13R)-Labda-11,14-Diene-8,13-Diol
Molecular Weight | 306.49 | nRot | 3 |
Heavy Atom Molecular Weight | 272.218 | nRig | 13 |
Exact Molecular Weight | 306.256 | nRing | 2 |
Solubility: LogS | -5.042 | nHRing | 0 |
Solubility: LogP | 4.079 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 57.675 |
nHD | 2 | BPOL | 34.109 |
QED | 0.755 |
Synth | 4.659 |
Natural Product Likeliness | 2.882 |
NR-PPAR-gamma | 0.033 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.484 |
Pgp-sub | 0.001 |
HIA | 0.015 |
CACO-2 | -4.42 |
MDCK | 0.00002 |
BBB | 0.295 |
PPB | 0.869542 |
VDSS | 1.196 |
FU | 0.0640989 |
CYP1A2-inh | 0.028 |
CYP1A2-sub | 0.295 |
CYP2c19-inh | 0.261 |
CYP2c19-sub | 0.792 |
CYP2c9-inh | 0.29 |
CYP2c9-sub | 0.449 |
CYP2d6-inh | 0.131 |
CYP2d6-sub | 0.108 |
CYP3a4-inh | 0.916 |
CYP3a4-sub | 0.552 |
CL | 3.317 |
T12 | 0.265 |
hERG | 0.031 |
Ames | 0.004 |
ROA | 0.383 |
SkinSen | 0.523 |
Carcinogencity | 0.047 |
EI | 0.497 |
Respiratory | 0.914 |
NR-Aromatase | 0.235 |
Antiviral | No |
Prediction | 0.511084 |